Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
暂无分享,去创建一个
P. Malfertheiner | A. Hartmann | R. Schneider-Stock | A. Roessner | D. Kuester | B. Peters | H. Lippert | F. Bataille | T. Guenther | A. Silver | U. Bohr | F. Meyer | P. Ruemmele | D. Schubert | S. Biesold
[1] P. Malfertheiner,et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. , 2008, Pathology, research and practice.
[2] Ruey-Hwa Chen,et al. The Tumor Suppressor Death-Associated Protein Kinase Targets to TCR-Stimulated NF-κB Activation1 , 2008, The Journal of Immunology.
[3] S. Itzkowitz,et al. Cancer in inflammatory bowel disease. , 2008, World journal of gastroenterology.
[4] A. Kimchi,et al. DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress , 2007, Cell Death and Differentiation.
[5] J. Issa,et al. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. , 2007, Gastroenterology.
[6] P. Malfertheiner,et al. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. , 2007, Neoplasia.
[7] J. Jass,et al. Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors. , 2007, American journal of clinical pathology.
[8] M. Vieth,et al. DAPK promotor methylation is an early event in colorectal carcinogenesis. , 2006, Cancer letters.
[9] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[10] P. Rabinovitch,et al. Cancer surveillance in inflammatory bowel disease: new molecular approaches , 2006, Current opinion in gastroenterology.
[11] A. Zinsmeister,et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. , 2006, Gastroenterology.
[12] R. Schneider-Stock,et al. Close localization of DAP‐kinase positive tumour‐associated macrophages and apoptotic colorectal cancer cells , 2006, The Journal of pathology.
[13] A. Forbes,et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.
[14] T. Ohkusa,et al. Disruption of the p53–p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis , 2006, International journal of cancer.
[15] G. Watanabe,et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer , 2006, British Journal of Cancer.
[16] J. Joseph,et al. Death-associated Protein Kinase as a Sensor of Mitochondrial Membrane Potential , 2005, Journal of Biological Chemistry.
[17] P. Marjoram,et al. The Molecular Signature of Normal Squamous Esophageal Epithelium Identifies the Presence of a Field Effect and Can Discriminate between Patients with Barrett's Esophagus and Patients with Barrett's-Associated Adenocarcinoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[18] C. Yu,et al. Aberrant CpG island methylation in early-onset sporadic gastric carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.
[19] Noam Harpaz,et al. Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. , 2005, Gastroenterology.
[20] T. Fujimori,et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis , 2005, Gut.
[21] S. Itzkowitz,et al. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[22] Alastair Forbes,et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.
[23] Hyeon Joo Lee,et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. , 2003, The American journal of pathology.
[24] K. Chayama,et al. The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis , 2003, Virchows Archiv.
[25] Tsung-Teh Wu,et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] S. Lam,et al. Epigenetic down-regulation of death-associated protein kinase in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] H. Kuwano,et al. High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. , 2003, Cancer letters.
[28] Jie Liao,et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. , 2003, Carcinogenesis.
[29] S. Toyooka,et al. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. , 2002, Cancer research.
[30] Nita Ahuja,et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. , 2002, Journal of the National Cancer Institute.
[31] F. Waldman,et al. The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.
[32] Suna Wang,et al. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. , 2002, Cancer research.
[33] N. Ahuja,et al. Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.
[34] P. Dickman,et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. , 2001, Gastroenterology.
[35] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[36] K. Abrams,et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.
[37] W. H. Kim,et al. CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.
[38] W. Bodmer,et al. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer , 2001, Gut.
[39] P. Dickman,et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study , 2001, The Lancet.
[40] P. Laird,et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.
[41] K Raja,et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.
[42] C. Fenoglio-Preiser,et al. Microsatellite instability and K-ras mutations in patients with ulcerative colitis. , 2000, Human pathology.
[43] S. Baylin,et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.
[44] A. Kimchi,et al. Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.
[45] H. Mitomi,et al. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[46] C. Hsieh,et al. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. , 1998, Cancer research.
[47] S. Polak‐Charcon,et al. DAP kinase links the control of apoptosis to metastasis , 1997, Nature.
[48] A. Kimchi,et al. DAP‐kinase is a Ca2+/calmodulin‐dependent, cytoskeletal‐associated protein kinase, with cell death‐inducing functions that depend on its catalytic activity , 1997, The EMBO journal.
[49] Sajeev P. Cherian,et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. , 1996, Cancer research.
[50] J. Benhattar,et al. Molecular genetics of dysplasia in ulcerative colitis. , 1995, European journal of cancer.
[51] N. Harpaz,et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.
[52] N. Harpaz,et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. , 1993, Gastroenterology.
[53] H. Adami,et al. Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.
[54] J. Lennard-jones,et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. , 1990, Gut.
[55] Makoto Watanabe,et al. Aberrant DNA methylation in ulcerative colitis without neoplasia. , 2008, Hepato-gastroenterology.
[56] Jia-Yun Chen,et al. TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase , 2002, Nature Cell Biology.
[57] Gustavo Droguett,et al. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.
[58] A. Kimchi,et al. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.